Elanco Net Income From Continuing Ops from 2010 to 2026
| ELAN Stock | USD 24.75 0.67 2.78% |
Net Income From Continuing Ops | First Reported 2016-12-31 | Previous Quarter 11 M | Current Value -34 M | Quarterly Volatility 214.2 M |
Check Elanco Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elanco Animal's main balance sheet or income statement drivers, such as Tax Provision of 181.1 M, Depreciation And Amortization of 516 M or Interest Expense of 409.3 M, as well as many indicators such as Price To Sales Ratio of 1.47, Dividend Yield of 0.0 or PTB Ratio of 1.68. Elanco financial statements analysis is a perfect complement when working with Elanco Animal Valuation or Volatility modules.
Elanco | Net Income From Continuing Ops | Build AI portfolio with Elanco Stock |
Evaluating Elanco Animal's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Elanco Animal Health's fundamental strength.
Latest Elanco Animal's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Elanco Animal Health over the last few years. It is Elanco Animal's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elanco Animal's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Elanco Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (162,205,294) | |
| Geometric Mean | 217,920,752 | |
| Coefficient Of Variation | (222.80) | |
| Mean Deviation | 250,534,948 | |
| Median | (210,800,000) | |
| Standard Deviation | 361,401,294 | |
| Sample Variance | 130610.9T | |
| Range | 1.5B | |
| R-Value | 0.19 | |
| Mean Square Error | 134210.1T | |
| R-Squared | 0.04 | |
| Significance | 0.46 | |
| Slope | 13,704,118 | |
| Total Sum of Squares | 2089774.3T |
Elanco Net Income From Continuing Ops History
About Elanco Animal Financial Statements
Elanco Animal investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Elanco Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 304.2 M | 319.4 M |
Pair Trading with Elanco Animal
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elanco Animal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elanco Animal will appreciate offsetting losses from the drop in the long position's value.Moving together with Elanco Stock
Moving against Elanco Stock
| 0.61 | SNY | Sanofi ADR | PairCorr |
| 0.61 | PTAIF | PT Astra International | PairCorr |
| 0.44 | PIFMY | Indofood Sukses Makmur | PairCorr |
| 0.42 | CNSP | CNS Pharmaceuticals | PairCorr |
| 0.37 | SNOA | Sonoma Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Elanco Animal could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elanco Animal when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elanco Animal - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elanco Animal Health to buy it.
The correlation of Elanco Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elanco Animal moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elanco Animal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elanco Animal can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Elanco Animal Correlation against competitors. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Will Pharmaceuticals sector continue expanding? Could Elanco diversify its offerings? Factors like these will boost the valuation of Elanco Animal. Projected growth potential of Elanco fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Elanco Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.167 | Earnings Share 0.07 | Revenue Per Share | Quarterly Revenue Growth 0.104 | Return On Assets |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Elanco Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elanco Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elanco Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.